Cancer 03/30

Revolutionizing Bladder Cancer Treatment: How AI is Personalizing Oncology Care

Revolutionizing Cancer Care with AI-Based Digital Twins and Python Simulations

Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca

STAT+: This Canadian company’s AI tool could help drugmakers cut risk in late-stage cancer trials

AI 'fingerprint' technology could bring cancer drugs to patients in half the current time

AI reads cancer cells’ 3D shape to predict their drug response

Predictive Oncology (POAI) Uses AI to Slash Drug Discovery Timelines & Boost Cancer Research

How Harnessing AI Can Transform Clinical Trials

AI Tool Helps Predict Who will Benefit from Focal Therapy for Prostate Cancer